What dosage of Morphine is recommended for end-of-life care?

In the context of end-of-life care, the administration of Morphine is often guided by the need to manage pain and alleviate discomfort for patients. A dose of 5 mg of Morphine is considered a practical starting point for many patients experiencing significant pain. This dosage strikes a balance between providing sufficient pain relief while minimizing the risk of oversedation, particularly in individuals whose tolerance to opioids may be varying due to their condition.

At end-of-life stages, patients often have changing sensitivities to medications, and starting with a moderate dose allows healthcare providers to assess the patient's response effectively. If pain is not adequately controlled, it can be titrated upwards as needed. Additionally, this approach respects the principle of individualized care, addressing the specific needs and comfort of each patient in their final days.

Dosages above 5 mg, while sometimes necessary for certain patients, can lead to excessive sedation or respiratory depression, particularly in those who may not have a history of opioid use. This makes the 5 mg option a prudent choice in balancing efficacy and safety for terminal care scenarios.